Home Tools
Log in
Cart

Search Result

Search Results for " movement disorders "

9

Compounds

Cat No. Product Name Synonyms Targets
T16980 Taminadenant Adenosine Receptor
Taminadenant is an adenosine receptor antagonist.
T9522 Rimtuzalcap CAD-1883 Potassium Channel
Rimtuzalcap (CAD-1883) (CAD-1883), a pioneering selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels), is employed in the study of movement disorders such as spin...
T71138L Binospirone MDL 73005EF 5-HT Receptor
Binospirone (MDL 73005EF) is a 5-HT1A receptor agonist with anxiolytic activity used in the study of glaucoma and movement disorders associated with neurologic dysfunction.
T0719 Tetrabenazine Xenazine,Ro 1-9569 Others , Dopamine Receptor , Monoamine Transporter
Tetrabenazine (Ro 1-9569) is a drug formerly used as an antipsychotic and treatment of various movement disorders. Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high...
T72170 NaV1.2/1.6 channel blocker-1 Sodium Channel
NaV1.2/1.6 channel blocker-1 is a potent NaV1.2/1.6 channel blocker with inhibitory effects on rNaV1.6 and hNaV1.2.NaV1.2 channel blocker-1 can be used in the study of generalised epilepsy and movement disorders.
T1751 Eliprodil SL-820715 NMDAR , iGluR
Eliprodil (SL-820715)(SL-820715), a non-competitive NR2B-NMDA receptor antagonist(IC50: 1 uM), less effective for NR2A- and NR2C-containing receptors(IC50> 100 uM). It has been used in trials studying the treatment of Pa...
T31264 Deanol acetamidobenzoate Deanol p-acetamidobenzoate,Elevan,Diforene,Cervoxan,Deaner
Deanol acetamidobenzoate is CNS stimulant. It can be caused elevated blood choline levels, can be used in Treatment of Choreiform Movement Disorders.
T26260 Tetrabenazine methanesulfonate NSC169886,NSC 169886,NSC-169886
Tetrabenazine methanesulfonate is a medicine formerly utilized as an antipsychotic and therapy for various movement disorders. Tetrabenazine methanesulfonate blocks neurotransmitter uptake into adrenergic storage vesicle...
T78827 CVN417
CVN417 is an orally active antagonist of nAChR containing the α6 subunit, modulating phasic dopaminergic neurotransmission in an impulse-dependent fashion. It inhibits Ca(2+) efflux through nAChR subunits, displaying IC5...
TargetMol